Dr. Volker Gerdts, Director and CEO, Vaccine and Infectious Disease Organization (VIDO)
The University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) has been a leader in COVID-19 research and development since the emergence of SARS-CoV-2. This includes being the first in Canada to isolate the virus, the first in Canada to develop an animal model, and the first Canadian university organization to have a vaccine in clinical trials.
In this webinar, you will:
- learn more about VIDO’s COVID-19 response
- find out about vaccine development during a pandemic, and
- hear about VIDO’s aims to improve Canada’s pandemic preparedness